7 Federal Agencies & Big Pharma Quietly Built A Pandemic-Industrial Complex
Authored by Jon Fleetwood via substack,
Nearly 14 years before COVID-19, HHS created the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) and centralized federal health, biomedical, regulatory, homeland-security, and military functions around a government-directed countermeasure pipeline.
Creating what this website refers to as the Pandemic-Industrial Complex (PIC).
PHEMCE centralized seven named federal agencies and components (ASPR, CDC, FDA, NIH, DOD, DHS, and VA) across four Cabinet departments: HHS, DOD, DHS, and VA.
Private industry was explicitly inserted into that structure.
HHS named pharmaceutical manufacturers, biotechnology companies, clinical research organizations, and private research organizations.
Then it proposed increasing industry access to HHS agencies, streamlining regulation, lowering obstacles to private investment, and applying liability protections.
The government’s own documents show the same apparatus stretching from threat detection and intelligence assessments through research, product development, regulation, procurement, stockpiling, deployment, and use.
The national-security conflict is obvious.
What happens when the government institutions helping define an alleged biological threat are centralized with the institutions funding research around it, determining what product should be made, regulating that product, buying it, and organizing its deployment?
And what happens if research financed or overseen ...
Continue Reading »